Status:
UNKNOWN
Intraoperative Cerebral and Renal Tissue Oxygen Saturation and Pediatric Living Donor Liver Transplantation Prognosis.
Lead Sponsor:
RenJi Hospital
Conditions:
Pediatric Liver Transplantation
Developmental Delay
Eligibility:
All Genders
6-36 years
Brief Summary
This rSO2 study is a prospective clinical study. The purpose of the rSO2 study is to investigate whether there is a correlation between the intraoperative cerebral and renal tissue oxygen saturation a...
Detailed Description
There is high incidence of developmental and socioemotional delay and postoperative complications in pediatric living donor liver transplantation patients. In this prospective observational clinical s...
Eligibility Criteria
Inclusion
- Pediatric patients (6 months\< the Moon's age \<36 months) who will receive standard living-donor liver transplantation (LDLT) in Renji Hospital.
Exclusion
- Forehead skin infection, A history of liver transplantation, Multivisceral transplantation, Refused to participate the study
Key Trial Info
Start Date :
September 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2024
Estimated Enrollment :
123 Patients enrolled
Trial Details
Trial ID
NCT04518332
Start Date
September 1 2020
End Date
December 31 2024
Last Update
October 4 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Renji Hospital
Pudong, Shanghai Municipality, China, 200127